Friday, January 23, 2026

Tilray Sees Cannabis Revenues Fall 16.6% In Second Quarter 2022

Tilray Inc (TSX: TLRY) this morning reported its fiscal second quarter results for the period ended November 30, while also announcing a name change. The firm will be changing its name to Tilray Brands, Inc, which is intended to “reflect the company’s evolution from a Canadian LP to a global consumer packaged goods company powerhouse.”

The firm reported net revenues of $155.2 million for the three month period, as compared to $168.0 million in the first quarter, a 7.7% decrease. Despite this, Irwin Simon, CEO of Tilray, commented, “The totality of our performance, our prospects and our global platform make Tilray Brands’ opportunity as compelling as ever, driven by our success as a cannabis and lifestyle CPG powerhouse.”

In terms of segments, the hit to revenue came from the firms cannabis segment, which declined from revenues of $70.4 million in Q1 to that of $58.8 million in Q2, a decline of 16.6% on a quarterly basis. Distribution revenue meanwhile climbed slightly from $67.2 million to $68.9 million. Beverage alcohol also fell, dropping from $15.5 million to $13.7 million, while wellness revenue fell from $14.9 million to $13.8 million.

Gross profit as a result was also down on a quarterly basis, from $51.0 million to $32.8 million.

On the positive side, total operating expenses fell from $119.5 million to $87.5 million, largely due to transaction costs falling from $25.6 million to $8.1 million. General and administrative also fell, dropping from $49.5 million to $33.5 million. Overall, the firm posted an operating loss of $54.7 million, an improvement from the $68.5 million loss recorded in the first quarter.

Following a non-operating income of $64.8 million however, along with an income tax recovery of $5.7 million, the firm managed to post a net income of $5.8 million. Adjusted EBITDA meanwhile amounted to $13.8 million,

The firms cash position meanwhile fell from $376.3 million to $331.8 million over the course of the quarter. Total current assets meanwhile fell from $844.6 million to $708.3 million. Current liabilities also fell, falling from $526.8 million to $314.9 million.

Tilray Inc last traded at $8.13 on the TSX.


Information for this briefing was found via Edgar and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Goliath Resources Accelerates Option Agreement On Golddigger While Reducing NSR

Related News

Tilray & Aphria: The Analyst Perspective

This morning it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray Inc...

Wednesday, December 16, 2020, 02:04:02 PM

Medmen Posts Q4 Loss Of $46.2 Million

Medmen Enterprises (CSE: MMEN) last night reminded investors why Canaccord Genuity had a long standing...

Friday, September 24, 2021, 07:29:00 AM

Tilray Obtains German Cannabis License Under New Regulations

Tilray Brands (TSX: TLRY) is reportedly in the process of expanding its operations in Germany,...

Monday, July 22, 2024, 09:31:50 AM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

The Public Partners of Westleaf

Westleaf Inc (TSXV: WL) is a $300 million company in which we can almost guarantee...

Monday, January 28, 2019, 02:00:06 PM